Clinical Trials Browser

Interventional × Lymphangioleiomyomatosis × 30 days × Clear all

NCT01799538 2026-03-11

Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis

Phase 1/2 Recruiting

Lymphangioleiomyomatosis

NCT03304678 2026-02-18

Discovery of Sirolimus Sensitive Biomarkers in Blood

Phase 2 Completed

33 enrolled 6 charts

Lymphangioleiomyomatosis